Charles C. Mann reports that significant government spending and a lack of restrictions on stem-cell research are making China the cloning capital of the world.

As China puts research funds into regenerative medicine, its scientists are starting to explore the field's technical and ethical frontiers. Carina Dennis visits the labs that are creating an international stir.